Transcatheter mitral valve replacement (TMVR) has emerged as a treatment option for patients with mitral regurgitation (MR), ineligible for surgery or transcatheter edge-to-edge repair. Anatomical conditions and clinical risk profiles differ substantially between women and men. Evidence on sex-specific difference...
I. von der Heide, A. Coisne, A. Duncan et al.· European Heart Journal· 0 citations
The extent of extravalvular CD correlates with AS severity and is associated with poor clinical outcomes across all AS stages, and further research is warranted to determine whether assessing CD should be integrated in the management of patients with AS.
A. Coisne, Rubens Groulez, Camille Diharce et al.· JACC: Advances· 0 citations
TTVR with the LuX-Valve Plus system to treat patients with severe or greater symptomatic TR and a large tricuspid annulus was associated with high intraprocedural and 30-day clinical success rates, significant TR reduction and functional improvement, and low permanent pacemaker implantation rates.
O. de Backer, Y. Lim, R. von Bardeleben et al.· EuroIntervention· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.